Turning on the thyroid: Researchers determine mechanism that triggers normal and abnormal hormone production

January 8, 2016, American Society for Biochemistry and Molecular Biology
Model of a glycoprotein hormone receptor (white backbone ribbon) with bound hormone and the activating antibody visualizes a potential arrangement and the principle mechanism of glycoprotein hormone receptor activation. Credit: Journal of Biological Chemistry doi: 10.1074/jbc.M115.701102

Thyroid disease affects about 12 percent of the U.S. population. While many people with thyroid disease don't even know they have it, an overactive or underactive thyroid can cause a slew of problems, including weight gain or loss, mood changes and infertility. In children, an underactive thyroid can be fatal, which is why they are tested for a deficiency at birth.

Despite the prevalence of and its sometimes serious effects, researchers have struggled to answer a pretty basic question about the hormone-producing gland: What turns it on? A study published in this week's issue of the Journal of Biological Chemistry provides an answer, and that answer was found within the gland itself. What's more, the researchers who made the discovery say their finding will aid in the design of therapies for thyroid problems, such as Graves' disease, and problems with other glands that operate in a similar fashion.

The is a hormone factory. Under normal conditions, the factory foreman—the molecule calling the shots—is the aptly named thyroid-stimulating hormone. Called TSH for short, this hormone attaches to a receptor on the thyroid cell surface, triggering a series of signals that provoke the gland to pump out .

However, sometimes autoantibodies, essentially posing as TSH, attach to the receptor and trick the thyroid into flooding the body with more hormones than are needed. In addition, sometimes the receptor itself has an inherited or acquired mutation that triggers production of too many or too few hormones.

Torsten Schöneberg of the University of Leipzig in Germany, who led the study reported in the JBC, says it was curious that the legitimate activator hormone, autoantibodies and mutations all were able to provoke . So his team set out to identify a common thread among them.

Turns out, the answer lay in the receptor itself.

"We discovered a small amino acid sequence - we call it p10 because it is 10 amino acids long—within the TSH receptor protein," Schöneberg explains. This sequence "functions as activator of the receptor upon binding of the hormone or autoantibodies."

In other words, the receptor itself flips the switch—when it should and when it shouldn't.

"In most other hormone-receptor systems, the hormone directly activates the receptor protein," says Antje Brüser, first author of the study and junior scientist of the group, offering the example of how adrenalin activates the ß . "In the case of glycoprotein hormone , the family of proteins that includes the thyroid receptor, upon binding of the extracellular hormone, the intramolecular activator (p10) induces structural changes of the receptor protein, triggering activation of the intracellular signaling cascade."

Now that researchers know from their cell studies that this family of receptors can essentially flip its own switch, they can use that information to design drugs to prevent that from happening when it shouldn't. "For example, in Graves' disease, autoantibodies directed against the TSH receptor stimulate the in an uncontrolled fashion, causing hyperthyroidism," Schöneberg says. "Our findings will promote the development of specific small-molecule drugs useful to treat Graves' disease and other dysfunctions of GPHRs."

Explore further: How do you get into downtown Cell City? It's kinda complicated

More information: Antje Brüser et al. The Activation Mechanism of Glycoprotein Hormone Receptors with Implications in the Cause and Therapy of Endocrine Diseases, Journal of Biological Chemistry (2016). DOI: 10.1074/jbc.M115.701102

Related Stories

Thyroid problems linked to irregular heart rhythm

November 28, 2012

People with an overactive thyroid gland (hyperthyroidism) carry a greater risk of developing irregular heart rhythm (known as atrial fibrillation) than those with normal thyroid function, finds a study published on BMJ today.

Recommended for you

Engineers test drug transfer using placenta-on-a-chip

February 16, 2018

Researchers at the University of Pennsylvania's School of Engineering and Applied Science have demonstrated the feasibility of their "organ-on-a-chip" platform in studying how drugs are transported across the human placental ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.